Health IT Vendor Veradigm Invests in Behavioral Health Data Analytics Company

Health IT vendor Veradigm Inc., formerly Allscripts Healthcare Solutions, Inc., has announced an investment in Holmusk, a behavioral health data analytics company.

Veradigm led Holmusk’s $45 million series B financing round with participation from current investors, including Heritas Capital, Health Catalyst Capital, Novartis (dRx Capital), and Northwell Holdings, the venture investment arm of Northwell Health, as well as other previous investors.

Holmusk will leverage this funding to continue the rapid expansion of its flagship offering, the NeuroBlu Database, which serves as a source of real-world clinical data for the behavioral health industry.

Veradigm and Holmusk plan to enter a data partnership to bring groups of behavioral health and related de-identified patient data from Veradigm to the NeuroBlu Database.

“Mental and behavioral health is a serious global health problem that has only increased during and post the COVID-19 pandemic,” Rick Poulton, Veradigm CEO, said in a press release. “Holmusk has proven expertise to create the evidence needed to improve mental health. We are proud to equip the company with the resources needed to advance this important work.”

“This investment will enable our team to continue its work in curating and enhancing data as we plan to build the world’s largest platform for behavioral health data,” Nawal Roy, Holmusk founder and CEO, noted. “We remain laser-focused on this mission because we know that quality data leads to improved evidence, which leads to better health outcomes.”

“We feel fortunate to form a partnership with Veradigm, a company that shares our vision for the transformative power that data can have in health care,” said Michael Weintraub, chair of the Holmusk Board. “Working collaboratively will help us to deepen our investment in the behavioral health space and make a broader impact.”